Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety
Author:
Affiliation:
1. Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7AL, UK
2. Physiological Laboratory, University of Cambridge, Cambridge, UK
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine
Link
http://academic.oup.com/ehjcvp/advance-article-pdf/doi/10.1093/ehjcvp/pvaa041/33144221/pvaa041.pdf
Reference10 articles.
1. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro;Liu;Cell Discov,2020
2. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro;Wang;Cell Res,2020
3. The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review;Haeusler;BMC Med,2018
4. Murine electrophysiological models of cardiac arrhythmogenesis;Huang;Physiol Rev,2017
5. Sodium channel haploinsufficiency and structural change in ventricular arrhythmogenesis;Jeevaratnam;Acta Physiol (Oxf),2016
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advance in the development of N-heterocyclic derivatives as anti-SARS-CoV-2 inhibitors: A review;Phytochemistry Letters;2024-06
2. Comparisons of the rate of acute myocardial infarction between COVID-19 patients and individuals received COVID-19 vaccines: a population-based study;2022-07-25
3. Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers;Clinical Pharmacology & Therapeutics;2022-06-22
4. Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed?;Frontiers in Cardiovascular Medicine;2022-03-09
5. Myth surrounding the FDA disapproval of hydroxychloroquine sulfate and chloroquine phosphate as drugs for coronavirus disease 2019;Coronavirus Drug Discovery;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3